Fermenta Biotech Ltd
Fundamental Score
Fermenta Biotech Ltd Share Price Live NSE/BSE
Profitability Metrics
Return on Equity
Return on Capital Employed
Operating Profit Margin (5Y)
Dividend Yield
Valuation Metrics
Price to Earnings
Market Capitalization
Industry P/E
Growth Metrics
YoY Quarterly Profit Growth
YoY Quarterly Sales Growth
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Financial Health
Debt to Equity
Interest Coverage
Free Cash Flow (5Y)
Ownership Structure
Promoter Holding
FII Holding
DII Holding
Pledged Percentage
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Market Data Analysis & Educational Insights
Educational evaluation of FERMENTA across key market metrics for learning purposes.
Positive Indicators
11 factors identified
Strong Return on Equity (24.88%)
Observation: Efficient use of shareholders' capital generating superior returns.
Analysis: ROE >15% indicates strong profitability and effective management. This metric suggests the company can generate substantial returns on invested capital.
Excellent ROCE Performance (22.97%)
Observation: Superior returns on capital employed across business operations.
Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance. This indicates quality business fundamentals.
Strong Operating Margins (15.97%)
Observation: Healthy 5-year operating margins indicate pricing power and cost control.
Analysis: OPM >15% suggests operational efficiency and competitive advantages. This indicates sustainable profitability potential.
Attractive Valuation (P/E: 7.30 vs Industry: 31.77)
Observation: Trading at discount to industry peers.
Analysis: P/E below industry average may present value opportunity if fundamentals support the business case.
Robust Profit Growth (65.91%)
Observation: Strong year-over-year profit expansion demonstrates business momentum.
Analysis: Profit growth >20% indicates effective execution and market opportunity capture. This suggests positive business trajectory.
Strong Revenue Growth (37.03%)
Observation: Healthy sales growth indicates market demand and execution capability.
Analysis: Revenue growth >15% suggests strong market position and growth potential. This indicates business expansion success.
Conservative Debt Levels (D/E: 0.29)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns and flexibility for growth investments.
Strong Interest Coverage (11.15x)
Observation: Earnings comfortably cover interest obligations.
Analysis: Interest coverage >5x indicates low financial distress risk and strong debt servicing capability.
Strong Cash Generation (₹213.64 Cr over 5Y)
Observation: Healthy free cash flow generation supports growth and returns.
Analysis: Strong FCF provides flexibility for dividends, debt reduction, and growth investments.
Balanced Promoter Holding (64.09%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment while ensuring adequate liquidity.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral, reducing forced-selling risk.
Analysis: Absence of share pledging eliminates potential forced-selling pressure during market stress.
Risk Factors
1 factors identified
Limited Institutional Interest (FII+DII: 0.02%)
Observation: Low institutional participation may affect liquidity and visibility.
Analysis: Limited institutional interest may indicate size constraints or visibility issues in the investment community.
Financial Statements
Comprehensive financial data for Fermenta Biotech Ltd
About FERMENTA
Business Overview
Fermenta Biotech Limited, together with its subsidiaries, manufactures and markets chemicals, bulk drugs, and enzymes in India, Europe, the United States, and internationally. It provides pharmaceutical formulations and environmental solutions; rents and sells properties; and sports and health awareness/education services. The company also offers various variants of vitamin D3, including crystalline oil, resin oil, cold water dispersible, and feed grade powder for use in various applications, such as pharmaceuticals, dietary and nutritional supplements, feed, injectables, soft gel capsules, premixes, food and beverage fortification, veterinary, feed, and rodenticides; pharmaceutical ingredients comprising phenyramidol and silicon dry powder; nutritional premixes; and enzymes for use in oleochemicals, fine chemicals, active pharmaceutical ingredients, food and fragrances, leather, and biodiesel industries. In addition, it engages in the design, engineering, procurement, and construction of water and wastewater treatment plants; and offers operations and maintenance services, as well as property development business. The company was formerly known as DIL Limited. Fermenta Biotech Limited was incorporated in 1951 and is based in Thane, India.
Company Details
Key Leadership
Corporate Events
Latest News
FERMENTA Stock Details & Analysis
Key Financial Metrics
Growth & Valuation
Frequently Asked Questions
What is the current price of Fermenta Biotech Ltd (FERMENTA)?
As of 29 Jan 2026, 10:35 am IST, Fermenta Biotech Ltd (FERMENTA) is currently trading at ₹310.15. The stock has a market capitalization of ₹818.18 (Cr).
Is FERMENTA share price Overvalued or Undervalued?
FERMENTA is currently trading at a P/E ratio of 7.30x, compared to the industry average of 31.77x. Based on this relative valuation, the stock appears to be Undervalued against its sector peers.
What factors affect the Fermenta Biotech Ltd share price?
Key factors influencing FERMENTA's price include its quarterly earnings growth (Sales Growth: 37.03%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is Fermenta Biotech Ltd a good stock for long-term investment?
Fermenta Biotech Ltd shows a 5-year Profit Growth of 7.00% and an ROE of 24.88%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.29 before investing.
How does Fermenta Biotech Ltd compare with its industry peers?
Fermenta Biotech Ltd competes with major peers in the Pharmaceuticals. Investors should compare FERMENTA's P/E of 7.30x and ROE of 24.88% against the industry averages to determine its competitive standing.
What is the P/E ratio of FERMENTA and what does it mean?
FERMENTA has a P/E ratio of 7.30x compared to the industry average of 31.77x. The Price-to-Earnings (P/E) ratio is calculated by dividing the current share price by earnings per share (EPS). This means investors are paying ₹7 for every ₹1 of annual earnings.
How is FERMENTA performing according to Bull Run's analysis?
FERMENTA has a Bull Run fundamental score of 67.5/100, which indicates moderate strength with some areas for improvement. This comprehensive rating is based on 15+ financial parameters including profitability, growth metrics, and valuation ratios.
What sector and industry does FERMENTA belong to?
FERMENTA operates in the Pharmaceuticals industry. This classification helps understand the competitive landscape and sector-specific trends affecting Fermenta Biotech Ltd.
What is Return on Equity (ROE) and why is it important for FERMENTA?
FERMENTA has an ROE of 24.88%, which indicates excellent management efficiency and profitable operations. Return on Equity measures how efficiently Fermenta Biotech Ltd generates profits from shareholders' equity.
How is FERMENTA's debt-to-equity ratio and what does it indicate?
FERMENTA has a debt-to-equity ratio of 0.29, which indicates conservative financing with low financial risk. A ratio below 1.0 generally indicates conservative financing.
What is FERMENTA's dividend yield and is it a good dividend stock?
FERMENTA offers a dividend yield of 0.90%, which means you receive ₹0.90 annual dividend for every ₹100 invested.
How has FERMENTA grown over the past 5 years?
FERMENTA has achieved 5-year growth rates of: Sales Growth 9.89%, Profit Growth 7.00%, and EPS Growth 7.00%.
What is the promoter holding in FERMENTA and why does it matter?
Promoters hold 64.09% of FERMENTA shares, with 0.00% of promoter shares pledged. High promoter holding often indicates strong management confidence.
What is FERMENTA's market capitalization category?
FERMENTA has a market capitalization of ₹818 crores, placing it in the Small-cap category.
How volatile is FERMENTA stock?
FERMENTA has a beta of N/A. A beta > 1 suggests the stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is the 52-week high and low for FERMENTA?
FERMENTA has a 52-week high of ₹N/A and low of ₹N/A.
What is FERMENTA's operating profit margin trend?
FERMENTA has a 5-year average Operating Profit Margin (OPM) of 15.97%, indicating the company's operational efficiency.
How is FERMENTA's quarterly performance?
Recent quarterly performance shows YoY Sales Growth of 37.03% and YoY Profit Growth of 65.91%.
What is the institutional holding pattern in FERMENTA?
FERMENTA has FII holding of 0.02% and DII holding of 0.00%. Significant institutional holding often suggests professional confidence in the stock.